{"entity":{"type":"insider","cik":"0001493383","url":"/insider/0001493383","json_url":"/insider/0001493383.json","name":"Berelowitz Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2014-04-02","last":"2018-03-13","span_basis":"filed_date"},"name_variants":[{"name":"Berelowitz Michael","source":"filing","n_filings":4,"first_seen":"2014-04-02","last_seen":"2018-03-13"}],"transactions":[{"id":6795585,"accession":"0001192482-18-000109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-18-000109","line_url":"/filing/0001192482-18-000109#line-2","is_derivative":false,"issuer_cik":"0001493383","issuer_name":"Recro Pharma, Inc.","issuer_ticker":"REPH","issuer_name_source":null,"issuer_url":"/issuer/0001493383","owner_cik":"0001493383","owner_name":"Berelowitz Michael","owner_display_name":"Berelowitz Michael","owner_url":"/insider/0001493383","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":10.4462,"price_display":"10.45","price_state":"stated","total_value":78346.5,"total_display":"78,346.50","total_whole":"78,347","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-09","filed_date":"2018-03-13","scope":"insider"},{"id":8929156,"accession":"0001213900-15-009392","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-15-009392","line_url":"/filing/0001213900-15-009392#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001493383","owner_name":"Berelowitz Michael","owner_display_name":"Berelowitz Michael","owner_url":"/insider/0001493383","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":9.44,"price_display":"9.44","price_state":"stated","total_value":6608.0,"total_display":"6,608.00","total_whole":"6,608","shares_owned_after":22896.0,"shares_owned_after_display":"22,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-09","filed_date":"2015-12-10","scope":"insider"},{"id":8649970,"accession":"0001213900-15-009373","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-15-009373","line_url":"/filing/0001213900-15-009373#line-2","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001493383","owner_name":"Berelowitz Michael","owner_display_name":"Berelowitz Michael","owner_url":"/insider/0001493383","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":761.0,"shares_display":"761","price_per_share":8.7,"price_display":"8.70","price_state":"stated","total_value":6620.7,"total_display":"6,620.70","total_whole":"6,621","shares_owned_after":23596.0,"shares_owned_after_display":"23,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-08","filed_date":"2015-12-09","scope":"insider"},{"id":8649968,"accession":"0001213900-15-009373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-15-009373","line_url":"/filing/0001213900-15-009373#line-1","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001493383","owner_name":"Berelowitz Michael","owner_display_name":"Berelowitz Michael","owner_url":"/insider/0001493383","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":539.0,"shares_display":"539","price_per_share":8.7,"price_display":"8.70","price_state":"stated","total_value":4689.3,"total_display":"4,689.30","total_whole":"4,689","shares_owned_after":24357.0,"shares_owned_after_display":"24,357","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-07","filed_date":"2015-12-09","scope":"insider"},{"id":6806804,"accession":"0001178913-14-001187","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001178913-14-001187","line_url":"/filing/0001178913-14-001187#line-3","is_derivative":false,"issuer_cik":"0001176309","issuer_name":"ORAMED PHARMACEUTICALS INC.","issuer_ticker":"ORMP","issuer_name_source":null,"issuer_url":"/issuer/0001176309","owner_cik":"0001493383","owner_name":"Berelowitz Michael","owner_display_name":"Berelowitz Michael","owner_url":"/insider/0001493383","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9434.0,"shares_display":"9,434","price_per_share":10.5,"price_display":"10.50","price_state":"stated","total_value":99057.0,"total_display":"99,057.00","total_whole":"99,057","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-31","filed_date":"2014-04-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001588972","name":"Recro Pharma, Inc.","url":"/issuer/0001588972","role":"Director","n_filings":1,"first_seen":"2018-03-13","last_seen":"2018-03-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001176309","name":"ORAMED PHARMACEUTICALS INC.","url":"/issuer/0001176309","role":"Director","n_filings":3,"first_seen":"2014-04-02","last_seen":"2015-12-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001493383","retrieved_at":"2026-08-23T02:50:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}